NSCLC patients with EGFR mutation were at a higher incidence of developing brain metastasis (BM). Patients with BM are associated with high mortality. Reducing BM incidence becomes increasingly significant for NSCLC patients to achieve prolonged survival. | Risk factors of metachronous brain metastasis in patients with EGFR-mutated advanced non-small cell lung cancer